Here are five things to know:
1. The recall is voluntary. It is due to a probable human carcinogen, n-nitrosodimethylamine, which was found in the products.
2. The U.S. recall includes versions of valsartan made by Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals.
3. Since valsartan is used to treat serious medical conditions, the FDA is advising that patients continue to take the recalled valsartan medication until they have a replacement product.
4. “We have carefully assessed the valsartan-containing medications sold in the U.S., and we’ve found that the valsartan sold by these specific companies does not meet our safety standards, said Janet Woodcock, MD, director of the FDA’s Center for Drug Evaluation and Research. “This is why we’ve asked these companies to take immediate action to protect patients.”
5. The U.S. joined Germany, Norway, Finland, Sweden, Hungary, the Netherlands, Austria, Ireland, Bulgaria, Italy, Spain, Portugal, Belgium, France, Poland, Croatia, Lithuania, Greece, Canada, Bosnia, Bahrain and Malta in issuing a recall of the products over a cancer risk, according to CNN.
Find the list of recalled valsartan products here.
More articles on pharmacy:
Packaging concerns force Novartis, Sandoz to recall 12 drugs
Pfizer stock value dips after Trump’s tweet
8 lesser-known facts about Pfizer
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.